Ke Wang

EGFRvⅢ-targeted immunotoxin combined with temozolomide and bispecific antibody for the eradication of established glioblastoma.

Mingqian Feng, Xiaobing Jiang, Xuan Wang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody.

Yaxi Yang, Mingqian Feng, Xiaoyan Wu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer.

Mingqian Feng, Xin Chen, Yuankui Zhu, 2023, Journal of cancer research and clinical oncology.

Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody.

Yaxi Yang, Mingqian Feng, Xiaoyan Wu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System

Yaxi Yang, Yuankui Zhu, Dianbao Zuo, 2024, Biomaterials research.